>>> Xerox beats by $0.01, misses on revs; guides Q4 EPS in-line; Board authorize

Xerox beats by $0.01, misses on revs; guides Q4 EPS in-line; Board authorizes review of business portfolio and capital allocation options

  • Reports Q3 (Sep) earnings of $0.24 per share, excluding non-recurring items, $0.01 better than the Capital IQ Consensus of $0.23; revenues fell 7.2% year/year to $4.45 bln vs the $4.55 bln Capital IQ Consensus.
  • Co issues in-line guidance for Q4, sees EPS of $0.28-0.30, excluding non-recurring items, vs. $0.29 Capital IQ Consensus Estimate.
  • Xerox expects full-year 2015 cash flow from operations of $1.6 to $1.7 billion and free cash flow from operations of $1.3 to $1.4 billion.
  • Board of Directors has authorized a review of the company's business portfolio and capital allocation options, with the goal of enhancing shareholder value.
    • "Xerox's Board of Directors and management team continually review the company's strategy and consider a range of opportunities regarding our businesses and operations with the goal of maximizing value for shareholders," said Ursula Burns, Xerox Chairman and Chief Executive Officer. "Although we already have taken steps to accelerate cost reductions and prioritize investments to drive improved productivity and higher margins, our Board determined that undertaking a comprehensive review of structural options for the company's portfolio is the right decision at this time."

>>> Oi / TIM : Press Release: Oi S.A.: Material Fact - Proposal for exclusivity

Press Release: Oi S.A.: Material Fact - Proposal for exclusivity of potential transaction that enables the consolidation of the

Oi S.A. ("Oi" or the "Company", Bovespa: OIBR3, OIBR4; NYSE: OIBR and OIBR.C), in accordance with Art. 157, paragraph 4 of Law No. 6,404/76, informs its shareholders and the market in general that BTG Pactual S.A. ("BTG Pactual"), in its capacity as the Company's agent to develop viable structuring and financing alternatives that would enable the Company to participate in the consolidation of the Brazilian telecommunications sector, without diluting the interests of current shareholders, received, on Friday, October 23, 2015, a letter from a company of the investment group Letter One ("Letter One"), containing a proposal for the Company to enter into exclusive negotiations with Letter One with respect to a potential transaction with the objective of a possible consolidation of the Brazilian telecommunications sector, involving a potential business combination with TIM Participacoes S.A.
In accordance with the proposal from Letter One, sent by BTG Pactual to the Chief Executive Officer and Chairman of the Company's board of directors, Letter One would be willing to make a capital contribution of up to U.S.$4.0 billion in the Company, subject to the consolidation activities.
The proposal will be carefully evaluated by the Company, jointly with its legal and financial advisors.
The Company will maintain its shareholders and the market informed if there is any decision with respect to the above matter or with respect to any events related to the foregoing.

WSJ : Citi Found Itself Briefly Exposed to $400 Million Hit

Citi Found Itself Briefly Exposed to $400 Million Hit
Executives discovered a giant potential loss; money is recovered

A small London hedge-fund firm and a lapse in bank-risk controls caused a panic inside Citigroup Inc. in July, after its executives discovered a series of trades they estimated could cost the bank as much as $400 million, people familiar with internal discussions at the time said.

The concerns made a brief appearance in the bank’s second-quarter earnings released July 16 in which Citigroup said it had reserved $175 million stemming from “valuation adjustments related to certain financing transactions,” but the details otherwise have remained a mystery.

Citigroup clawed back all of the money at risk in the next three months. But the slip-up adds to a series of technology snafus at global banks and is reverberating inside the U.S. lender, which has worked to fix shortcomings in its systems and oversight.

“This is a systems problem,” said Janet Tavakoli, president of Chicago consulting firm Tavakoli Structured Finance Inc., adding that banks too often don’t adequately supervise their trading and financing activities with hedge-fund clients. “There’s a pattern where bankers are asking fewer questions in order to bring in more fees,” she said.

A Citigroup spokeswoman said the bank has no remaining exposure to the problem. “As soon as we detected this isolated issue through a regular review process, it was escalated to senior management, and we immediately put additional controls in place to prevent a similar event from occurring,” she said.

In June, Deutsche Bank AG accidentally transferred $6 billion to a hedge fund’s custody account, far more than intended, according to a person familiar with the matter. The bank got its money back.

In August, Bank of New York Mellon Corp. suffered a third-party software glitch that temporarily prevented the bank from accurately pricing more than 1,000 mutual funds and exchange-traded funds, causing headaches for asset managers. The bank apologized and has been analyzing the causes to prevent similar problems.

Citigroup’s problem was rooted in the bank’s prime-brokerage unit, which handles trades and extends loans to hedge funds while holding their assets. The trades in mostly bonds were made by LNG Capital LLP, a London hedge fund run by 52-year-old Louis N. Gargour and a Citigroup prime brokerage client since 2011, according to the people familiar with the matter.

LNG is a small fund, with about $150 million in assets. Most of its trades went through automated systems with infrequent human interaction on Citigroup’s part, the people said. On the dates LNG entered trades, Citigroup’s systems erroneously assigned higher than intended values to the bonds LNG held in its account, the people said.

According to the people, the systems got tripped up by expecting buy and sell orders to settle together, effectively canceling each other out. Instead, with some of the trades, which went on through May and June, one leg actually didn’t settle for weeks. As a result, Citigroup inadvertently kept extending credit to LNG, allowing it to buy about five times the value of securities as would have been allowed under normal risk limits, even as risks mounted for the bank.

An internal review flagged the issue in early July. Neil Warrender, a longtime operations and compliance consultant working for LNG, said that Citigroup “panicked” when it discovered the problem. LNG couldn’t immediately pay what Citigroup demanded, about $400 million, so Citigroup had to wait months for LNG to sell the positions, the people familiar with the matter said.

In announcing the $175 million reserve in July, Citigroup said it expected to recover all of the money.

Mr. Warrender said LNG simply made use of available financing. “If you put on trades and they don’t like them, they usually tell you right away,” he said. “LNG is a tiny company, and Citi is a giant company.”

Mr. Gargour said in an interview that LNG was operating “business as usual.” In a later email, he said his firm, like many hedge funds, has borrowed money from banks and was asked to reduce the leverage. He said LNG hasn’t caused any losses for Citigroup and said its trades “have on the whole been profitable.”

Citigroup has been reorganizing its prime brokerage business, which suffered significant losses in January when clients’ currency bets soured.

The positions that triggered the bank’s alarms, said Mr. Warrender, involved “not the most liquid bonds in the world.” A list reviewed by The Wall Street Journal shows bonds concentrated in companies connected with another private investment firm, Sapinda Holding BV, which has offices in London and Berlin.

The securities included debt and equities issued by agricultural and energy companies that are core holdings of Sapinda, as well as debt issued by Sapinda Invest Sarl, a Luxembourg-based investment vehicle, according to the list. A registered officer for Sapinda Invest said its beneficiary is the family trust of Lars Windhorst, a German businessman who is chairman of Sapinda Holding.

The trades involving the Sapinda-related bonds were the result of a new investment in LNG earlier this year, Mr. Warrender said. He said LNG’s contact for the investment was “through a family office,” which he said was Sapinda.

Ben Ullmann, an outside spokesman for Sapinda and Mr. Windhorst, said in an emailed statement, “Sapinda has no business relationship with LNG and no Sapinda affiliate has invested in LNG or received financing from LNG.”

Mr. Gargour said in an emailed statement, “LNG has no business relationship with Sapinda and no Sapinda affiliated entity has invested in LNG or has received financing from LNG.”

Citigroup has told LNG that its relationship is over, people familiar with the matter said. “We probably don’t want to work with them either,” Mr. Warrender said.

(GS) Orange : Back to growth for the first time in six years; reiterate CL-Buy

Back to growth for the first time in six years; reiterate CL-Buy

We believe Orange's return to growth is sustainable and with the stock
currently trading at a 13% 2017E FCF yield, valuation is attractive. 3Q15
results highlighted Oranges' increasingly premium position in a benign and
modestly inflationary market, allowing the company to increase prices,
improve customer mix and grow ARPU. With ongoing underlying domestic
cost-cutting and African/Spanish organic growth acceleration, this produced
the first quarter of revenue and EBITDA growth in 6 years. We argue Orange
has a multi-year self-help opportunity, compounding modest top-line
growth to drive a +5.3% 4-year EBITDA CAGR. We reiterate our CL Buy.

Catalyst
1) Earnings momentum – our 2016/17 group EBITDA forecasts are
+4.7%/+8.0% ahead of company-compiled consensus driven by our more
constructive view on top-line growth and cost cutting in France. We also
believe consensus reflects no benefit from the recent reinvestment into
Africa, the improved market growth outlook following recent consolidation
in Spain. 2) French spectrum auction – this unlikely to be a negative
catalyst in our view. The reserve price for each of the six 5MHz blocks is
already high at €416 mn and the structure of the auction process makes it
hard for operators to “bid up” the price. We also note that Bouygues and
NMC-SFR said they have limited need for more spectrum.

Valuation
Our raised underlying numbers and longer-term growth outlook drive our
12m ROIC-based target price to €21 (from €20). At our target price Orange
would trade at a 9% 2017E FCF yield vs. sector average of 7.2%.

Key risks
1) Numericable re-focusing on top-line sustainability. This is unlikely to
come in the form of price cuts, but it could bring increased cost competition
that could raise competitive intensity more broadly. 2) Slower-than
expected cost-cutting at Orange.

BArron's : WPP’s Prospects Shine in Global Ad Market

WPP’s Prospects Shine in Global Ad Market
U.K. giant should make net gains as up to $30 billion in advertising contracts go up for grabs.

Advertising giant WPP could see a downward blip in sales due to its emerging-market exposure, but it is well placed to win new business. It also boasts solid financials, and its shares looks inexpensive.

Indeed, the stock (ticker: WPP.UK) could climb as much as 20% in the next 12 months as the London-based company continues to grind out higher sales and improves returns to shareholders.

At Friday’s London close of 14.80 pounds ($22.71), the shares trade at less than 14.7 times projected 2016 earnings. Among advertisers’ big five, only France’s Publicis Groupe (PUB.France) has a lower price/earnings multiple—12.5, on the same basis—and it faces structural issues after its aborted merger last year with Omnicom (OMC). Omnicom fetches 15.8 times; Interpublic Group (IPG), 16.7; and Dentsu (4324.Japan), more than 21.

WPP’S SHARES HAVE almost doubled in the past five years, but are up only 9% in 2015, trailing gains of roughly 15% in both the Stoxx Europe 600’s consumer-services sector and media subsector. WPP, which has a market value of £19 billion, also has American depositary receipts (WPPGY), which were trading on Friday afternoon above $113. Each ADR represents five ordinary shares.

With the stock attractively priced, generating a 7.8% free-cash-flow yield and a 3% dividend, it could be worth £17.50 in a year. Some analysts even have price targets north of £20.

A large number of big advertising accounts are up for review this year, including those of Procter & Gamble (PG) and Unilever (UN). The annual billings at stake could be as high as $30 billion, and WPP units, including J. Walter Thompson, Ogilvy & Mather, Grey, and Y&R, seem well placed to add new business.

Digital ads are expected to overtake television ads by 2018, and WPP generates more than 40% of its revenue online. Total revenue was £11.53 billion last year, with North America, Western Europe, and emerging markets each accounting for roughly a third. This global footprint gives WPP some protection against the downturn in emerging markets.

Revenue is expected to be flat in 2015, but earnings should rise, on improved margins and better cost control. WPP is likely to earn 93 pence ($1.43) a share this year, up from 85 pence last year. In 2016, EPS is projected at £1.01 on £12.13 billion in revenue.

WPP has a track record of increasing generosity toward shareholders; the amount returned to them totaled £971 million last year. Claudio Aspesi, a senior analyst at Sanford C. Bernstein, estimates that the total will hit £1.3 billion by 2018, assuming stock buybacks equivalent to 2% of the shares annually. He rates WPP Outperform, with a price target of £18.50.

The payout ratio—the portion of profits paid out as dividends—has risen to 45% from just 29% in 2010. During that time, WPP has cut its ratio of net debt to earnings before interest, tax, depreciation, and amortization from 2.1 to 1.6. That’s toward the bottom of its target range of 1.5 to two, leaving scope for leverage.

If WPP were producing an ad for itself, it wouldn’t be hard. All it would have to do is focus on its sound fundamentals and strong prospects.

>>> GlaxoSmithKline shareholder Woodford Investment Management pushing for break

GlaxoSmithKline shareholder Woodford Investment Management pushing for break-up

GlaxoSmithKline [LON: GSK] (GSK) shareholder Woodford Investment Management is urging the FTSE-100 pharmaceuticals company to consider a break-up, Sky News reported.

The exclusive report cited insiders speaking on Saturday, 24 October who said Woodford Investment Management founder Neil Woodford has discussed the issue in private with GSK Chairman Philip Hampton.

Woodford wants GSK to formally look into splitting of its dermatology business, its consumer healthcare arm Stiefel and its HIV unit ViiV from its vaccines and medicines division, according to the report.

It is understood that Woodford and Hampton have scheduled another meeting to discuss the break-up proposal and that Woodford has also sounded out other key GSK shareholders, the item noted.

GSK has indicated that it wants to shift its focus from prescription drugs to consumer products and vaccines, the article noted.

Several large GSK investors are still supportive of CEO Andrew Witty’s strategy, the report said, quoting one investor who said it would be premature to examine GSK’s structure as the upside from the company’s deals with Swiss counterpart Novartis has not yet been delivered.

GSK has acquired Novartis’ vaccines business, sold its oncology arm to Novartis and formed a consumer healthcare venture with the Swiss company, the item noted.

The report went on to cite another person familiar with GSK who said the company’s core pharmaceuticals and vaccines arm had been fully integrated and would, therefore, make a break-up a more difficult process.

It is not known exactly how large of a stake Woodford holds in GSK, but it is less than the 5% that would prompt Woodford to formally disclose the shareholding, the article said.

Spokespersons for GSK and Woodford refused to comment, according to the report.

GlaxoSmithKline's market capitalisation stood at GBP 66.62bn (EUR 92.09bn) at the close of trading in London on Friday, 23 October.

Link to original source


Source Sky News

>>> Aberdeen Asset Management spokesman denies CEO approaches potential buyers

Aberdeen Asset Management spokesman denies CEO approaches potential buyers

An Aberdeen Asset Management [LON:ADN] spokesman has denied that founder and CEO Martin Gilbert is looking to sell the UK-based investment firm, the Financial Times reported.

The spokesman was cited as saying that neither an informal or formal approach to potential buyers has ever been made by Gilbert in his 32 years with the firm running the business.

The comment was in response to the item which reported citing people familiar with the matter that Gilbert has informally contacted several rivals over past months. One source said Gilbert is happy to stay independent while not denying that he has made approaches, the item noted, adding that Gilbert would not comment.

The business could attract funds in the US, UK and Asia as well as private equity firms Blackstone, Warburg Pincus and KKR, the report said, citing analysts. Bank insiders were quoted as saying that Deutsche Bank and Credit Suisse have indicated that their interest in asset management has been re-ignited though any acquisitions in the near term won't be likely.

Aberdeen Asset Management bought Deutsche Bank's institutional fund business in the UK and US in 2005, and seven years ago, it also snapped up a big portion of the global fund management business of Credit Suisse, as reported.

Financial Times